NCT00676221View on ClinicalTrials.gov

Patient Reported Outcomes in Renal Transplant Patients Tolerating Gastrointestinal (GI) Symptoms Converted to Myfortic (EC-MPS)

PHASE4UnknownINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

August 31, 2008

Study Completion Date

September 30, 2008

Conditions

Kidney Transplant

Interventions

DRUG

Myfortic

"Mycophenolate Mofetil (Cellcept) discontinued at Baseline visit. Mycophenolate Sodium(Myfortic)commenced the following day at equimolar doses orally BID.~Cellcept 1000mg bid = Myfortic 720mg bid"

Trial Locations (1)

T2N2T9

Foothills Medical Centre, Calgary